Inventor · disambiguated record
Jose M. Lora
Also filed as: LORA JOSE · LORA JOSE M
4 granted patents·23 pending applications·15 citations·filing 2001–2022
70Inventor score
Top patents by PatentIndex Score
27 records- 0193US11471494B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2018·Granted Oct 18, 2022·7 cites·10 claims
- 0281US6911317B22150, human protein kinase family member and uses thereforMILLENNIUM PHARM INC·Filed 2002·Granted Jun 28, 2005·8 cites·34 claims
- 0369US2023226122A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 0462US7303902B22150, human protein kinase family member and uses thereforMILLENNIUM PHARM INC·Filed 2007·Granted Dec 4, 2007·0 cites·9 claims
- 0561US2009226448A1Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 0661US2009226449A1Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 0760US2009226450A1Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 0859US2023332164A1Bacteria engineered to secrete active proteinsSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 0957US7211392B22150, human protein kinase family member and uses thereforMILLENNIUM PHARM INC·Filed 2005·Granted May 1, 2007·0 cites·11 claims
- 1057US2006122373A1Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereofMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 1155US2024409975A1Synthetic production of circular dna vectorsINTERGALACTIC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1254US2007281306A1Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2006·Application pending·0 cites
- 1350US2022370637A1Chitosan polyplex-based localized expression of il-12 alone or in combination with type-i ifn inducers for treatment of mucosal cancersENGENE INC·Filed 2020·Application pending·0 cites
- 1450US2003219806A1Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 1549US2005260702A1Novel integrin alpha subunit and uses thereofMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 1649US2023210995A1Localized expression of therapeutic nucleic acids in lung epithelial cellsANTHONY CHEUNG·Filed 2021·Application pending·0 cites
- 1748US2024148902A1Combination gene therapy for treatment of metastatic cancerENGENE INC·Filed 2022·Application pending·0 cites
- 1847US2011171205A1Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2011·Application pending·0 cites
- 1945US2009226434A1Afucosylated antibodies against CCR5 and their use for the treatment of inflammatory conditionsROCHE PALO ALTO LLC·Filed 2009·Application pending·0 cites
- 2045US2020149053A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2018·Application pending·0 cites
- 2144US2002142377A118607, a novel human calcium channelFiled 2001·Application pending·0 cites
- 2243US2003039991A146798, a human matrix metalloproteinase and uses thereforMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2342US2022023358A1Combination therapies of microorganisms and immune modulators for use in treating cancerSYNLOGIC OPERATING CO INC·Filed 2019·Application pending·0 cites
- 2441US2016024504A1Treating th2-mediated diseases by inhibition of bromodomainsGENENTECH INC·Filed 2014·Application pending·0 cites
- 2540US2022226397A1Synergistic combinations of arginine-producing bacteria and/or ammonia-consuming bacteria and checkpoint inhibitors and methods of use thereofSYNLOGIC OPERATING CO INC·Filed 2020·Application pending·0 cites
- 2636US2016317632A1Use of cbp/ep300 bromodomain inhibitors for cancer immunotherapyGENENTECH INC·Filed 2016·Application pending·0 cites
- 2733US2018221362A1Ezh2 inhibitors and modulation of regulatory t-cell functionCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jose M. Lora files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →